Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Return on Equity: 2024-2025

Historic Return on Equity for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to -0.83%.

  • Mereo BioPharma Group's Return on Equity fell 23.00% to -0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.83%, marking a year-over-year decrease of 23.00%. This contributed to the annual value of -0.78% for FY2024, which is 20.00% down from last year.
  • Per Mereo BioPharma Group's latest filing, its Return on Equity stood at -0.83% for Q3 2025, which was up 4.87% from -0.87% recorded in Q2 2025.
  • Mereo BioPharma Group's Return on Equity's 5-year high stood at -0.56% during Q1 2024, with a 5-year trough of -0.87% in Q2 2025.
  • For the 2-year period, Mereo BioPharma Group's Return on Equity averaged around -0.70%, with its median value being -0.65% (2024).
  • Data for Mereo BioPharma Group's Return on Equity shows a maximum YoY declined of 26bps (in 2025) over the last 5 years.
  • Mereo BioPharma Group's Return on Equity (Quarterly) stood at -0.65% in 2024, then decreased by 23bps to -0.83% in 2025.
  • Its Return on Equity stands at -0.83% for Q3 2025, versus -0.87% for Q2 2025 and -0.78% for Q1 2025.